PMC:7402624 / 16472-16693 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T112","span":{"begin":36,"end":39},"obj":"Body_part"},{"id":"T113","span":{"begin":50,"end":55},"obj":"Body_part"},{"id":"T114","span":{"begin":131,"end":135},"obj":"Body_part"}],"attributes":[{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A113","pred":"fma_id","subj":"T113","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}

{"project":"LitCovid-PubTator","denotations":[{"id":"511","span":{"begin":31,"end":35},"obj":"Gene"},{"id":"512","span":{"begin":44,"end":47},"obj":"Gene"},{"id":"513","span":{"begin":125,"end":128},"obj":"Gene"},{"id":"521","span":{"begin":204,"end":212},"obj":"Species"},{"id":"532","span":{"begin":81,"end":83},"obj":"Disease"},{"id":"533","span":{"begin":195,"end":203},"obj":"Disease"}],"attributes":[{"id":"A511","pred":"tao:has_database_id","subj":"511","obj":"Gene:952"},{"id":"A512","pred":"tao:has_database_id","subj":"512","obj":"Gene:925"},{"id":"A513","pred":"tao:has_database_id","subj":"513","obj":"Gene:925"},{"id":"A521","pred":"tao:has_database_id","subj":"521","obj":"Tax:9606"},{"id":"A532","pred":"tao:has_database_id","subj":"532","obj":"MESH:D006816"},{"id":"A533","pred":"tao:has_database_id","subj":"533","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T125","span":{"begin":81,"end":83},"obj":"Disease"},{"id":"T126","span":{"begin":195,"end":203},"obj":"Disease"}],"attributes":[{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T260","span":{"begin":31,"end":35},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T261","span":{"begin":44,"end":47},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T262","span":{"begin":48,"end":55},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T263","span":{"begin":125,"end":128},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T264","span":{"begin":129,"end":135},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T265","span":{"begin":136,"end":146},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T266","span":{"begin":151,"end":152},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T267","span":{"begin":214,"end":215},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T82","span":{"begin":40,"end":42},"obj":"Chemical"},{"id":"T83","span":{"begin":81,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A83","pred":"chebi_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T41","span":{"begin":129,"end":146},"obj":"http://purl.obolibrary.org/obo/GO_0042110"},{"id":"T42","span":{"begin":131,"end":146},"obj":"http://purl.obolibrary.org/obo/GO_0001775"}],"text":"ts had no increase in KI67+ or CD38+HLA-DR+ CD8 T cells above the level found in HD (Fig. 2, E and F). Thus, although robust CD8 T cell activation was a clear characteristic of many hospitalized COVID-19 patients, a subst"}